Search Results

Berchiche obtained her Master’s and Ph.D. in Biochemistry at the University of Montreal in Canada before She received her undergraduate degree in Biotechnology from KIIT University in India. Monserrat Avila Zozaya I did a PhD in cell biology at CINVESTAV, Mexico. About John Azietaku John Teye Azietaku,PhD is a trained pharmacist, holding a Ph.D. in Drug Discovery Biology his expertise to enhance healthcare outcomes and contribute to the growth of the pharmaceutical and biotech

Chemical biologist Johannes Broichhagen reveals how fluorescent probes transform GPCR imaging, internalization GPCR Podcast, chemical biologist Dr. Why this matters How a chemist with zero biology training became a leader in GPCR probe design. Who should listen If you’ve ever: Navigated a project where the biology refused to match the textbook Collaborated across chemistry and biology and felt the translation gap firsthand… …this episode will

the functional diversity of bitter taste receptors means for novel therapeutic targets beyond sensory biology receptor regulation—work that sparked his ongoing engagement with receptor signaling and microdomain biology Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology) at Mount Sinai School of Medicine (City University In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Les Houches, France in 1979 where he was exposed for the first time to the nascent field of membrane biophysics Rockefeller University with a Howard Hughes Medical Institute appointment, Tom advanced a series of novel biochemical and biophysical assay platforms, including FTIR and Raman microprobe spectroscopy to study micro-quantities applications included “targeted photo-crosslinking,” and more recently, the parallel development of bioorthogonal Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

I received my PhD in Biology at Arizona State University, where I worked in the lab of Miles Orchinik I joined the faculty of Biomedical Sciences at Marquette in 2007. I teach undergraduate Biochemistry and a variety of graduate neuroscience courses. Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Tried to map signaling heterogeneity in disease-relevant models, Built assays that need to work in real biology—not Michelle Halls is an Associate Professor at Monash University and Deputy Theme Leader of Drug Discovery Biology Michelle earned her PhD in Molecular Pharmacology at Monash University, then trained in single-cell biology Join a global GPCR community of scientists and biotech leaders. 👉 Join now Upcoming Live Expert Sessions Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Andrew Tobin Andrew Tobin studied Biochemistry at Queen Mary College, the University of London obtaining research laboratory of around 15 staff supported by basic research grants investigating aspects of disease biology Andrew is translating fundamental findings to commercial products is Keltic Pharma Therapeutics Ltd , a biotechnology Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Discovering these receptors would be a significant breakthrough in cardiovascular biology as they could My long-term plan is to conduct research in the field of receptor biology, with a focus on GPCRs. Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

2021 Clarivate Analytics Highly Cited Researcher in two disciplines: Pharmacology & Toxicology and Biology & Biochemistry, a corresponding member of the International Union of Basic and Clinical Pharmacology Sexton is also a co-founder of the San Francisco-based biotechnology company Septerna Inc . Dr. Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Claudia Stäubert "I received my degree in biochemistry from Leipzig University (Germany) being already Since 2014, I have led a research group at the Rudolf Schönheimer Institute of Biochemistry in Leipzig Claudia Stäubert on the web Stäubert Lab, Rudolf Schönheimer Institute of Biochemistry Leipzig LinkedIn Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

He works in a multidisciplinary Chemical Biology team based at the recently established US R&D hub in Originally from Łódź, Poland, Jacek completed his Master's degree in Biology, specializing in Biochemistry Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

After spending two years at the Cleveland Institute of Art, he earned degrees in Biochemistry and Chemistry He then went on to earn a Ph.D. in Molecular Biophysics from Johns Hopkins University, followed by postdocs Miller School of Medicine in 2016, where he is currently a practicing molecular pharmacologist and biophysicist , systems and synthetic biologist, technologist, heavy CRISPR user, protein sequence- and structure-based Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

He later joined the laboratory of eminent biochemical pharmacologist, Dr. Alfred G. His training has provided a strong foundation and appreciation for the applications of pharmacology, biochemistry and structural biology to delineate mechanisms of action. The Sunahara lab utilizes biochemical, biophysical and pharmacological methodologies to study GPCR-G Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Moro, that he truly saw how molecules could go beyond the bench and interact with biology in powerful The Moment Chemistry Met Biology Nicoli’s turning point came when he realized that molecules weren’t static—they could act , bind , and modulate biological targets. For Nicoli, chemistry became more than reactions—it became a bridge to biological insight. Alessandro Nicoli on the web Leibniz Institute for Food Systems Biology at the Technical University of

Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . Trained as a biochemist, he completed a PhD in protein engineering (Cambridge, UK) with Sir Gregory Winter Oliver Hartley on the web LinkedIn Orion Biotechnology Dr. Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

FB is recognized for her expertise and pioneering works in the field of biological and pathological functions Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor Biology To broaden his biomedical skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Adjunct Director of the VIB Center for Molecular Neurology and also Vice-Chair of the Department of Biomedical Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor Biology

Foord reflects on his path from academic neuroendocrinology to introducing molecular biology and molecular pharmacology into Glaxo’s GPCR programs, and on the combination of rigor, bioinformatics, and serendipity Deorphanizing Receptors Blends Bioinformatics and Bench Work . Dr. As Head of Bioinformatics for Neuroscience, Dr. Reflecting on his path from physiology to molecular pharmacology to bioinformatics, Dr.

Kaavya Krishna Kumar on the web Journal of Biology Chemistry Stanford University Google Scholar LinkedIn Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Brian Hudson About Brian Hudson Brian is a lecturer in the School of Molecular Biosciences at the University Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

We have developed an array of fluorescent biosensors to map kinase activity in living cells and are exploring Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Ross Cheloha is an Investigator at the National Institutes of Health in the Laboratory of Bioorganic Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology